Drug sensitivity of pleomorphic Trypanosoma rhodesiense.
Explore the source record for details and available documents.
Animals↗
SEARCH · Search PubMed
Results for “Quinolinium Compounds”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Carcinogenicity testing of selected food additives by parenteral administration to infant Swiss mice.
Explore the source record for details and available documents.
Adenocarcinoma↗
Hypersensitivity of diabetic human platelets to platelet activating factor.
Platelet activating factor (PAF) stimulated aggregation and [32P]-phosphatidic acid (PA) production was compared in normal and diabetic human subjects in platelet rich plasma. The concentration of PAF for half maximal (50%) aggregation of normal and diabetic platelets was 50 nM and 8 nM, respectively. PAF stimulated [32P]-PA production (a metabolite of phospholipase C pathway) was also greater in the platelets from diabetic subjects. This [32P]-PA production was inhibited by the PAF receptor antagonists SRI-63441 and SRI-63675. When the levels of glycosylated hemoglobin (HbA1c) were compared with the PAF stimulated [32P]-PA production a significant relationship was observed. These studies have demonstrated for the first time that diabetic human platelets show hypersensitivity to PAF in both aggregation and [32P]-PA production compared to normal subjects. This may be a result of some modification in phospholipid turnover mechanism and is receptor mediated. Further, the relationship of the degree of aggregation and [32P]-PA production to the level of HbA1c suggest that the insulin deficiency may contribute to these effects.
Blood Platelets↗
Myeloid differentiation of HL-60 cells induced by anti-tumor drug 3-nitrobenzothiazolo[3,2-a]quinolinium.
Drugs which elicit cell differentiation might have an important role in the treatment of leukemias and other neoplasias. Various chemotherapeutic agents promote leukemic cell differentiation. The HL-60 cell line is a useful model to study in vitro myeloid differentiation. Sublethal concentrations of 3-nitrobenzothiazolo[3,2-a]quinolinium (NBQ), an antitopoisomerase II drug, were given to HL-60 cells from one to five days to evaluate its capacity to induce differentiation. NBQ-induced HL-60 cells reduced nitroblue tetrazolium (NBT), increased MY-4 receptors, increased phagocytic activity and displayed the granulocytic morphology. Flow cytometric DNA analysis of NBQ-induced cells revealed an arrest in the G1 phase a reduction in the relative percentage of cells in S and G2+M phases. Our results suggest that NBQ induces an S-phase specific differentiation of HL-60 cells comparable to that previously described with dimethyl sulfoxide and retinoic acid. NBQ and its analogs, as differentiation inducers, may have potential utility as a novel therapeutic modality for leukemias.
Cell Cycle↗
Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog.
Intravenous administration of platelet-activating factor (PAF) produces dose-dependent hypotension in several species. We have evaluated a recently developed PAF antagonist, SRI 63-441, for its ability to inhibit the hypotensive effect of PAF in the rat and dog. In the rat, 100 ng/kg PAF produced a 38.6 +/- 5.1% decrease in carotid mean arterial pressure (MAP), followed by a 3.2 +/- 0.7 min recovery period for MAP to return to baseline values. SRI 63-441 reduced the hypotension response in the rat, where the ED50 values for inhibition of MAP were 0.16 mg/kg i.v. and 0.19 mg/kg i.v. for the recovery period. Dogs challenged with 1.5 micrograms/kg PAF i.v. demonstrated a 52 +/- 8% decrease in MAP that persisted for at least 15 min. The ED50 for inhibition of MAP by SRI 63-441 was 0.20 mg/kg i.v. Following injection of tritium-labeled SRI 63-441, 56.8 +/- 2.4% of the dose was recovered in the urine and 43.2 +/- 8.9% in the feces in the rats while in dogs 38.7 +/- 5.6% and 60.9 +/- 23.5% of the dose was excreted in the urine and feces, respectively. In the rat model of endotoxin-induced hypotension, SRI 63-441 given 1 min after a 5 mg/kg endotoxin challenge (which produced a 52 +/- 7% decrease in MAP), reversed the systemic effects, with an ED50 of 0.18 mg/kg i.v. The ED50 for reversal 6 min after endotoxin injection was 0.01 mg/kg. These results of inhibition and reversal by SRI 63-441 strongly implicate PAF as a pivotal mediator of hypotension and shock.
Animals↗
Recent studies on inhibitors of macromolecular synthesis and function in trypanosomes.
Explore the source record for details and available documents.
Adenosine↗
Optical imaging of intracellular chloride in living brain slices.
We developed an optical imaging technique to measure changes in intracellular levels of Cl- in neurons within the living brain slice. After rat brain slices were incubated with the permeant form of the Cl(-)-sensitive dye, 6-methoxy-N-ethylquinolinium chloride (MEQ), neurons could be imaged within the hippocampus, cerebral cortex and cerebellum using fluorescence microscopy. Both soma and dendrites were clearly visible in pyramidal neurons, interneurons, Purkinje cells and cerebellar granule cells. Increased intracellular levels of Cl- were produced by bath application of the inhibitory neurotransmitter, gamma-aminobutyric acid (GABA). Within hippocampal pyramidal neurons and interneurons, GABA produced a concentration-dependent decrease in fluorescence (EC50 = 200 microM). The GABA response was mediated via the GABA receptor since it was blocked by picrotoxin and mimicked by the agonist, muscimol. Muscimol, which is not transported by the GABA re-uptake pump, was approximately 20-fold more potent than GABA. The method developed was also used to image intracellular Cl- levels with UV laser scanning confocal microscopy. Even greater resolution was obtained and deeper structures could be imaged in cerebral cortex and hippocampus. This is the first demonstration of optical imaging to measure intracellular Cl- dynamics in living brain slices using fluorescence microscopy and laser scanning confocal microscopy.
Animals↗
Absence of mutagenicity of the antitumor drug 3-nitrobenzothiazolo[3,2-a]quinolinium chloride (NBQ) in the germ cells of Drosophila melanogaster males.
The antitumor drug, 3-nitrobenzothiazolo[3,2-a]quinolinium chloride (NBQ) was tested for genotoxicity with the sex-linked recessive lethal test by feeding Drosophila melanogaster males. Although toxic to adults, the drug tested negative at the concentrations studied.
Animals↗
Activation and inactivation of purified acetylcholinesterase from Electrophorus electricus by lanthanum (III).
Explore the source record for details and available documents.
Acetylcholinesterase↗
Effects of high pressure on the single-turnover kinetics of the carbamylation of cholinesterase.
Pressure, as a perturbing variable, is one of the most powerful tools to investigate the thermodynamic parameters of chemical reactions and to study the mechanism of enzyme-catalyzed reactions. The effect of elevated hydrostatic pressure (up to 0.8 kbar) on the reaction of butyrylcholinesterase with N-methyl-(7-dimethylcarbamoxy)quinolinium was determined under single-turnover conditions at 35 degrees C. The rate of carbamylation was monitored as the accumulation of the fluorescent ion, N-methyl-7-hydroxyquinolinium, in a high-pressure stopped-flow apparatus designed for the assay of fluorescence. Elevated pressure favored formation of the enzyme-substrate complex but inhibited carbamylation of the enzyme. Because a single reaction step was recorded, it was possible to interpret the data obtained under high pressure in the form of Michaelis-Menten equations. From the pressure dependence of the dissociation constant for the enzyme-substrate complex and the rate constant for carbamylation, maximal volume changes accompanying these events were determined. The value for the binding process, delta Vb = -129 ml.mol-1, is too large to be related only to volumetric changes in the active center. Substrate-induced conformational change and change of water structure appear to be the dominant contributions to the overall volume change associated with substrate binding. The large positive activation volume measured (delta V not equal to = 119 ml.mol-1) may also reflect extended structural and hydration changes. At pressures greater than 0.4 kbar, an additional pressure effect, dependent on substrate concentration, occurred in a narrow pressure interval. This effect may have resulted from a substrate-induced pressure-sensitive enzyme conformational state.
Butyrylcholinesterase↗
Inhibition of Ehrlich ascites tumor in vivo by PAF-antagonists.
Several lines of evidence support that PAF modulates the inflammatory and immune responses, and that tumors may inhibit both these processes. In the present study we analysed the effect of PAF antagonists on the growth of Ehrlich Ascites Tumor (EAT) in vivo. Mice were inoculated intraperitoneally with 1 x 10(3) EAT cells and the tumor growth evaluated by counting the number of peritoneal cells, 1,6 and 10 days after tumor implantation. BN 52021 was administered intraperitoneally, intravenously or subcutaneously once or twice a day, at 1.0, 2.5, 5.0 and 20.0 mg/kg. Control animals received 0.1 ml of the vehicle in the same schedule. It was found that i.p. and i.v. administration of BN 52021 (5 mg/kg, twice a day) significantly inhibited EAT growth (80.8% and 56.0% respectively). Other routes and doses were less effective. Another PAF antagonist, SRI 63441 (5 mg/kg, i.p., twice a day) also inhibited EAT growth (80.4%). The BN 52021 added to EAT cells in culture, at concentration of 10(-3) and 10(-4) M, did not affect the viability and proliferation of tumors cells. In an attempt to understand the mechanism of this inhibition, we analyzed the peritoneal macrophages for spreading ability and H2O2 release. It was found that 24 h after tumor implantation there was an increase in the spreading ability of peritoneal macrophages (75%) and that, as the tumor grew, the spreading index fell to control levels ( less than 10%). (5 mg/kg/twice a day) the spreading remained elevated (50-60%) at all the times examined. Release of H2O2, measured by horseradish peroxidase-phenol red oxidation, was below detectable levels throughout tumor growth.(ABSTRACT TRUNCATED AT 250 WORDS)
Animals↗
Determination of GABA receptor-linked Cl- fluxes in rat cerebellar granule cells using a fluorescent probe SPQ.
Gamma-Aminobutyric acid (GABA)-induced Cl- fluxes in cultured rat cerebellar granule cells were measured using the chloride-sensitive fluorescent probe SPQ (6-methoxy-N-(3-sulphopropyl)quinolinium) incorporated into the cells. The fluorescence of SPQ is quenched by Cl-ions. GABA and pentobarbitone increased the fluorescence of the probe when the Cl- gradient was directed outward by bathing cells, grown in the presence of GABA, in a low Cl- medium. Picrotoxin and bicuculline inhibited the response to GABA. The results suggest that SPQ is a suitable probe for measuring GABA-induced Cl- fluxes in living cells.
Animals↗
Elimination of the gametocytes of Theileria annulata of cattle by primaquin phosphate.
Calves were experimentally infected with Theileria annulata and five drugs were administered in an attempt to exterminate the gametocytes of the parasite. The results of the experiment proved that primaquin phosphate is an effective parasiticide. The gametocytes from 30 calves treated with primaquin phosphate were exterminated completely. A further eight calves were treated with sulfamethoxypyrazine, trimethoprim, naganin and acaprin, but these drugs were not found to be effective in eliminating the gametocytes. The phase, size and colour of the gametocytes in these calves were the same as those of the four untreated control calves.
Animals↗
Effects of trypanocides on Herpetosoma in a mammalian feeder layer cell culture.
Limited studies have been undertaken on the treatment of infections with trypanosomes of the subgenus Herpetosoma, either in comparative studies on the effects of trypanocidal drugs or as potential non-pathogenic models for evaluating trypanocidal activities. The development of an in vitro cell culture system is described which enabled testing of trypanocides against 5 different species of Herpetosoma. The trypanocides used were Samorin, Novidium, Trypacide and Berenil. Variations were observed in the trypanocidal activity of the drugs on the different Herpetosoma parasites, e.g. T. lewisi and Samorin and T. microti and Novidium, compared with other parasites. Minimum effective concentration of Trypacide and Berenil against 5 Herpetosoma trypanosomes were of the order 10 mg ml-1. The results indicate that these parasites are much less sensitive to the drugs used than pathogenic, salivarian trypanosomes.
Animals↗
Trypanosoma evansi infection in dogs: seasonal prevalence and chemotherapy.
A 1-year survey was undertaken to determine the incidence of Trypanosoma evansi in dogs at Ludhiana, India. Of 64 dogs examined by wet film, thin smear, thick smear and mouse inoculation, three (4.68%) were found to be positive for T. evansi. All the positive animals were detected during the rainy and post-rainy seasons. The treatment of three infected dogs with a combination of quinpyramine sulphate and chloride (3:2 w/w) resulted in complete recovery of two dogs; another dog died on the day therapy was initiated.
Animals↗
A comparison of the antigen detection ELISA and parasite detection for diagnosis of Trypanosoma evansi infections in camels.
Two herds of 60 camels each, living in Trypanosoma evansi endemic areas, were selected and studied for a period of 18 months. Animals in one herd were treated prophylactically with quinapyramine prosalt (May and Baker, Dagenham, UK), while those in the other herd were treated individually with quinapyramine dimethylsulphate (May and Baker, Dagenham, UK) when proven parasitaemic. The herd on prophylaxis was sampled for antigen and patent infection monthly. The other herd was sampled weekly for patent infection and fortnightly for antigen. The results obtained could be divided into four categories. The first category comprised cases (52 out of 61) in which the presence of trypanosome antigens could be correlated with parasitological diagnosis. In 80% of these animals the antigens disappeared from the circulation within a period of 30 days following chemotherapy. The second category comprised those animals with parasitologically proven infections but which did not have antigens in their sera. This was observed in nine camels, seven of which were from the herd that was being examined weekly for the presence of trypanosomes. These were considered to be animals in early infection, as the subsequent sera were also negative for anti-trypanosome antibodies and immune complexes. The third category comprised camels which were antigen-positive but aparasitaemic. Sera from these animals were also positive for anti-trypanosome antibodies, indicating that antigen-positivity was a true reflection of trypanosome infections in these animals. The last category comprised pre-weaned camel calves which appeared to have some form of protection against trypanosomiasis, as evidenced by the absence of trypanosomes, antigens and antibodies throughout the early period of their lives. Only occasional antigenaemia was found in a few calves. It is concluded that trypanosome antigen detection may give a more accurate idea of the prevalence of T. evansi infections than does whole parasite detection.
Animals↗
Photochemistry of aqueous solutions of benzazolo[3,2-a]quinolinium salts. A spin-trapping study using 17O-enriched water and oxygen.
The photolysis of buffered aqueous solutions containing the quinolinium salts, 3-nitro-7-ethyl-benzimidazolo[3,2-a]quinolinium perchlorate (NEBQClO4) and 3-nitrobenzothiazolo[3,2-a]quinolinium chloride (NBQCl), at 344 and 365 nm, respectively, was studied in the presence of the spin trap 5,5-dimethyl-1-pyrroline-1-oxide (DMPO). Only a water-derived DMPO-OH.spin-adduct was obtained for both of these salts, at a DMPO concentration of 14 mM, as confirmed by H2 17O-enriched water experiments. A photosolvated intermediate is postulated as the OH donating species. Lower steady-state concentrations of the spin adduct were obtained in argon-saturated solutions, implying that oxygen gas is at least partially necessary in the water-derived DMPO-OH formation. Evidence for superoxide ion formation was obtained by the DMPO-17OH spin-adduct formation during the photolysis of NBQCl in an 17O-enriched oxygen atmosphere in the presence of 150 mM DMPO. An increase in the DMPO-OH steady-state concentration was observed if the photolysis of NBQCl was performed in the presence of superoxide dismutase (SOD). Our results suggest that this effect is due to the SOD inhibition of the destruction of DMPO-OH.by superoxide ion.
Algorithms↗
Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells.
The effect of platelet-activating factor on the intracellular cytosolic level of free calcium ([Ca2+]i) was studied in neurohybrid NCB-20 cells. In fura-2-loaded NCB-20 cells, platelet-activating factor induced an immediate and concentration-dependent increase in [Ca2+]i with a maximum increase of 334 +/- 27 nM above a basal value of 147 +/- 6 nM (n = 40). Platelet-activating factor-induced [Ca2+]i mobilization was inhibited by the platelet-activating factor antagonists BN 50739, WEB 2086, SRI 63-441 and BN 52021 in a dose-dependent manner with IC50 values of 12, 38, 897 and 45000 nM, respectively. The calcium-channel blockers nifedipine (10 microM) and diltiazem (10 microM) had no effect on the platelet-activating factor-induced increase in [Ca2+]i; however, extracellular Ca(2+)-depletion caused a 63.6 +/- 4.7% reduction of platelet-activating factor-induced increase in [Ca2+]i (n = 5, P less than 0.001). The remaining 36% contributed from intracellular sources was completely inhibited by 10 microM of 8-(N,N-diethylamine)octyl 3,4,5-trimethoxytenzoate hydrochloride (TMB-8). NCB-20 cells exhibited homologous desensitization to sequential addition of platelet-activating factor, but no heterologous desensitization between platelet-activating factor and bradykinin or ATP was observed. These data suggest that activation of the neuronal platelet-activating factor receptor results in an increase in [Ca2+]i primarily via a receptor-operated rather than a voltage-dependent calcium-channel and to a lesser extent from intracellular Ca2+ release. Our findings may contribute to an understanding of the mechanism of platelet-activating factor actions on neuronal cells.
Animals↗